Special Issue "Glioblastoma"

Quicklinks

A special issue of Cancers (ISSN 2072-6694).

Deadline for manuscript submissions: closed (30 June 2013)

Special Issue Editors

Guest Editor
Prof. Dr. Shi-Yuan Cheng
Department of Neurology, Northwestern Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center University of Northwestern Feinberg School of Medicine, 303 East Superior, Lurie 7-119, Chicago, IL 60026, USA
Website: http://www.biology.northwestern.edu/igp/faculty/cheng_s-y/index.html
E-Mail: shiyuan.cheng@northwestern.edu
Interests: oncogenic signaling; glioblastomas; breast cancers; cancer biology; molecular mechanisms of human cancer tumorigenesis, progression, invasion/metastasis and angiogenesis

Guest Editor
Prof. Dr. Frank Furnari
Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, CA 92093-0660, USA
Website: http://pathology.ucsd.edu/faculty/furnari.htm?id=247
E-Mail: ffurnari@ucsd.edu
Phone: +1 858 534 7819
Fax: +1 858 534 7750
Interests: glioma; tumor heterogeneity; EGFR; PTEN; targeted therapeutics; receptor tyrosine kinases

Special Issue Information

Dear Colleagues,

Neoplasms of glial cells, especially astrocytes, comprise 40-50% of the tumors that arise in the central nervous system. The most aggressive and deadly of these neoplasms is glioblastoma multiforme (GBM). Despite rapidly increasing knowledge of the gliomagenic lesions that underlie these tumor phenotypes and decades of technological advances in neurosurgery, radiation therapy and clinical trials of conventional and novel therapies, little improvement in the median survival of 12-15 months has been achieved for GBM patients. Therefore, it is essential and urgent that we improve our current knowledge of the molecular and cellular mechanisms of GBM initiation, progression and resistance to therapy. This special issue will focus on new advances in the molecular and cellular aspects of the pathophysiology of GBM and novel therapeutic approaches to eradicate this deadly brain cancer.
We are looking forward to your contributions.

Prof. Dr. Shi-Yuan Cheng
Prof. Dr. Frank Furnari
Guest Editors

Submission

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed Open Access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 800 CHF (Swiss Francs).

Keywords

  • molecular mechanisms of gliomagenesis and progression and therapy resistance
  • glioma stem cells
  • cancer metabolism
  • therapies for malignant gliomas
  • pathology/genomics
  • miRNAs
  • glioma tumor heterogeneity

Published Papers (15 papers)

Download All Papers
Sort by:
Display options:
Select articles Export citation of selected articles as:
Select/unselect all
Displaying article 1-15
p. 1953-1985
by , , ,  and
Cancers 2014, 6(4), 1953-1985; doi:10.3390/cancers6041953
Received: 2 June 2014; in revised form: 5 August 2014 / Accepted: 3 September 2014 / Published: 29 September 2014
Show/Hide Abstract | PDF Full-text (687 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Glioblastoma)
p. 723-740
by  and
Cancers 2014, 6(2), 723-740; doi:10.3390/cancers6020723
Received: 13 February 2014; in revised form: 13 March 2014 / Accepted: 14 March 2014 / Published: 26 March 2014
Show/Hide Abstract | PDF Full-text (353 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Glioblastoma)
p. 226-239
by ,  and
Cancers 2014, 6(1), 226-239; doi:10.3390/cancers6010226
Received: 1 November 2013; in revised form: 23 December 2013 / Accepted: 9 January 2014 / Published: 27 January 2014
Show/Hide Abstract | Cited by 2 | PDF Full-text (471 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Glioblastoma)
p. 1469-1484
by , ,  and
Cancers 2013, 5(4), 1469-1484; doi:10.3390/cancers5041469
Received: 22 October 2013; Accepted: 24 October 2013 / Published: 8 November 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (530 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Glioblastoma)
p. 1456-1468
by  and
Cancers 2013, 5(4), 1456-1468; doi:10.3390/cancers5041456
Received: 11 October 2013; Accepted: 24 October 2013 / Published: 7 November 2013
Show/Hide Abstract | PDF Full-text (343 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Glioblastoma)
p. 1379-1412
by ,  and
Cancers 2013, 5(4), 1379-1412; doi:10.3390/cancers5041379
Received: 16 September 2013; in revised form: 24 October 2013 / Accepted: 24 October 2013 / Published: 1 November 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (573 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Glioblastoma)
p. 1271-1305
by , , ,  and
Cancers 2013, 5(4), 1271-1305; doi:10.3390/cancers5041271
Received: 3 October 2013; Accepted: 15 October 2013 / Published: 23 October 2013
Show/Hide Abstract | PDF Full-text (1466 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Glioblastoma)
p. 1306-1331
by , , , ,  and
Cancers 2013, 5(4), 1306-1331; doi:10.3390/cancers5041306
Received: 22 September 2013; in revised form: 8 October 2013 / Accepted: 10 October 2013 / Published: 23 October 2013
Show/Hide Abstract | Cited by 4 | PDF Full-text (540 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Glioblastoma)
p. 1199-1211
by
Cancers 2013, 5(4), 1199-1211; doi:10.3390/cancers5041199
Received: 5 August 2013; in revised form: 16 August 2013 / Accepted: 18 August 2013 / Published: 25 September 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (559 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Glioblastoma)
p. 1177-1198
by , , , , , , , , ,  and
Cancers 2013, 5(3), 1177-1198; doi:10.3390/cancers5031177
Received: 1 July 2013; in revised form: 12 August 2013 / Accepted: 10 September 2013 / Published: 24 September 2013
Show/Hide Abstract | Cited by 3 | PDF Full-text (593 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Glioblastoma)
p. 1120-1139
by  and
Cancers 2013, 5(3), 1120-1139; doi:10.3390/cancers5031120
Received: 15 July 2013; in revised form: 13 August 2013 / Accepted: 19 August 2013 / Published: 3 September 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (544 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Glioblastoma)
p. 1103-1119
by ,  and
Cancers 2013, 5(3), 1103-1119; doi:10.3390/cancers5031103
Received: 29 June 2013; in revised form: 14 August 2013 / Accepted: 19 August 2013 / Published: 22 August 2013
Show/Hide Abstract | Cited by 5 | PDF Full-text (400 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Glioblastoma)
p. 1020-1048
by , , , , , ,  and
Cancers 2013, 5(3), 1020-1048; doi:10.3390/cancers5031020
Received: 29 June 2013; in revised form: 29 June 2013 / Accepted: 2 August 2013 / Published: 14 August 2013
Show/Hide Abstract | Cited by 2 | PDF Full-text (508 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Glioblastoma)
p. 1049-1071
by ,  and
Cancers 2013, 5(3), 1049-1071; doi:10.3390/cancers5031049
Received: 26 June 2013; in revised form: 29 July 2013 / Accepted: 1 August 2013 / Published: 14 August 2013
Show/Hide Abstract | Cited by 4 | PDF Full-text (3801 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Glioblastoma)
p. 357-371
by , , , , , , , , , , , , , , , , , , ,  and
Cancers 2013, 5(2), 357-371; doi:10.3390/cancers5020357
Received: 18 February 2013; in revised form: 18 March 2013 / Accepted: 22 March 2013 / Published: 3 April 2013
Show/Hide Abstract | Cited by 3 | PDF Full-text (1300 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Glioblastoma)
Select/unselect all
Displaying article 1-15
Select articles Export citation of selected articles as:

Last update: 12 November 2012

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert